BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12631412)

  • 1. Profound difference in pharmacokinetics between morin and its isomer quercetin in rats.
    Hou YC; Chao PD; Ho HJ; Wen CC; Hsiu SL
    J Pharm Pharmacol; 2003 Feb; 55(2):199-203. PubMed ID: 12631412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of metabolic pharmacokinetics of baicalin and baicalein in rats.
    Lai MY; Hsiu SL; Tsai SY; Hou YC; Chao PD
    J Pharm Pharmacol; 2003 Feb; 55(2):205-9. PubMed ID: 12631413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of baicalin and baicalein with antibiotics in the gastrointestinal tract.
    Xing J; Chen X; Sun Y; Luan Y; Zhong D
    J Pharm Pharmacol; 2005 Jun; 57(6):743-50. PubMed ID: 15969929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and pharmacokinetics of 3,3',4',7-tetrahydroxyflavone (fisetin), 5-hydroxyflavone, and 7-hydroxyflavone and antihemolysis effects of fisetin and its serum metabolites.
    Shia CS; Tsai SY; Kuo SC; Hou YC; Chao PD
    J Agric Food Chem; 2009 Jan; 57(1):83-9. PubMed ID: 19090755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in absorption of the two structurally similar flavonoid glycosides, hyperoside and isoquercitrin, in rats.
    Chang Q; Zuo Z; Chow MS; Ho WK
    Eur J Pharm Biopharm; 2005 Apr; 59(3):549-55. PubMed ID: 15760736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary flavonoids as antioxidants in vivo: conjugated metabolites of (-)-epicatechin and quercetin participate in antioxidative defense in blood plasma.
    Terao J
    J Med Invest; 1999 Aug; 46(3-4):159-68. PubMed ID: 10687310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and bioavailability of the flavonol quercetin in humans.
    Graefe EU; Derendorf H; Veit M
    Int J Clin Pharmacol Ther; 1999 May; 37(5):219-33. PubMed ID: 10363620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered pharmacokinetics of paclitaxel by the concomitant use of morin in rats.
    Choi BC; Choi JS; Han HK
    Int J Pharm; 2006 Oct; 323(1-2):81-5. PubMed ID: 16806758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinations of morin, quercetin and their conjugate metabolites in serum.
    Hsiu SL; Tsao CW; Tsai YC; Ho HJ; Chao PD
    Biol Pharm Bull; 2001 Aug; 24(8):967-9. PubMed ID: 11510497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin.
    Manach C; Morand C; Texier O; Favier ML; Agullo G; Demigné C; Régérat F; Rémésy C
    J Nutr; 1995 Jul; 125(7):1911-22. PubMed ID: 7616308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and bioavailability of the bioflavonoid biochanin A: effects of quercetin and EGCG on biochanin A disposition in rats.
    Moon YJ; Morris ME
    Mol Pharm; 2007; 4(6):865-72. PubMed ID: 17970592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption and enterohepatic circulation of baicalin in rats.
    Xing J; Chen X; Zhong D
    Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption and urinary excretion of quercetin, rutin, and alphaG-rutin, a water soluble flavonoid, in rats.
    Shimoi K; Yoshizumi K; Kido T; Usui Y; Yumoto T
    J Agric Food Chem; 2003 Apr; 51(9):2785-9. PubMed ID: 12696973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-administration of quercetin and catechin in rats alters their absorption but not their metabolism.
    Silberberg M; Morand C; Manach C; Scalbert A; Remesy C
    Life Sci; 2005 Nov; 77(25):3156-67. PubMed ID: 15979103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral bioavailability of quercetin from different quercetin glycosides in dogs.
    Reinboth M; Wolffram S; Abraham G; Ungemach FR; Cermak R
    Br J Nutr; 2010 Jul; 104(2):198-203. PubMed ID: 20230651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative pharmacokinetics of dihydroquercetin in rats upon peroral administration of a parent compound and liposomal flamen D].
    Zherdev VP; Kolyvanov GB; Litvin AA; Sariev AK; Viglinskaia AO; Gekkiev BI; Grigor'ev AM; Gorlov VV
    Eksp Klin Farmakol; 2010 Jan; 73(1):23-5. PubMed ID: 20184284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the flavonol quercetin on the bioavailability of simvastatin in pigs.
    Cermak R; Wein S; Wolffram S; Langguth P
    Eur J Pharm Sci; 2009 Dec; 38(5):519-24. PubMed ID: 19804821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of oral bioavailability of genistein and genistin in rats.
    Kwon SH; Kang MJ; Huh JS; Ha KW; Lee JR; Lee SK; Lee BS; Han IH; Lee MS; Lee MW; Lee J; Choi YW
    Int J Pharm; 2007 Jun; 337(1-2):148-54. PubMed ID: 17280808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of morin on the bioavailability of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats.
    Shin SC; Piao YJ; Choi JS
    In Vivo; 2008; 22(3):391-5. PubMed ID: 18610753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of morin on the pharmacokinetics of etoposide in rats.
    Li X; Yun JK; Choi JS
    Biopharm Drug Dispos; 2007 Apr; 28(3):151-6. PubMed ID: 17315145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.